Physician offers ‘SmartPill’ GI monitoring system
HealthLeaders News Brief, May 8, 2007
Leonard S. Fischer, M.D., gastroenterologist with Fairfax, VA-based Gastrointestinal Medicine Associates, has deployed the SmartPill GI Monitoring System, a company press release says. The SmartPill GI Monitoring System aids in the evaluation of patients with gastrointestinal motility disorders, including those suffering from symptoms of slow gastric emptying, a condition known as gastroparesis. Symptoms of gastroparesis include heartburn, nausea, vomiting of undigested food, abdominal bloating, erratic blood glucose levels and spasms of the stomach wall.
The condition affects a wide range of patients, including up to an estimated 50 percent of diabetics, as well as those suffering from Parkinson’s disease. “With SmartPill, there are clear improvements in the diagnosis of motility disorders in patients-and better control of monitoring conditions for physicians,” Fischer said. “It is a great opportunity to offer patients SmartPill, particularly because it is administered in an office setting, does not involve radiation and is very easy to tolerate.”
The SmartPill pH.p Capsule is a wireless, ingestible medical device - about the size of a large vitamin pill - that measures pressure and pH, gastric emptying time, combined small and large bowel transit time, and total transit time. The capsule travels through the gastrointestinal tract, collecting and transmitting data to the SmartPill Data Receiver. The receiver, slightly larger than a cell phone, is worn on a patient’s belt or around the neck on a lanyard.
A patient ingests the single-use SmartPill pH.p Capsule in the doctor’s office and then returns to their daily activities. Within a day or two, the disposable capsule is excreted naturally from the body. The patient then returns to the doctor, who downloads the information from the SmartPill Data Receiver.
The condition affects a wide range of patients, including up to an estimated 50 percent of diabetics, as well as those suffering from Parkinson’s disease. “With SmartPill, there are clear improvements in the diagnosis of motility disorders in patients-and better control of monitoring conditions for physicians,” Fischer said. “It is a great opportunity to offer patients SmartPill, particularly because it is administered in an office setting, does not involve radiation and is very easy to tolerate.”
The SmartPill pH.p Capsule is a wireless, ingestible medical device - about the size of a large vitamin pill - that measures pressure and pH, gastric emptying time, combined small and large bowel transit time, and total transit time. The capsule travels through the gastrointestinal tract, collecting and transmitting data to the SmartPill Data Receiver. The receiver, slightly larger than a cell phone, is worn on a patient’s belt or around the neck on a lanyard.
A patient ingests the single-use SmartPill pH.p Capsule in the doctor’s office and then returns to their daily activities. Within a day or two, the disposable capsule is excreted naturally from the body. The patient then returns to the doctor, who downloads the information from the SmartPill Data Receiver.
Most Viewed
Most Emailed
- Health insurers offer to accept all applicants, on condition
- Moody's reports question health of healthcare industry
- HCA job cuts may affect 100 employees
- Report: Fundamentals of Healthcare Will Change by 2020
- Obama to nominate Daschle as HHS Secretary
- Ted Kennedy asks Hillary Clinton to head Senate healthcare team
- What's Your Brand?
- UPMC's risky drive for revenue
- Tom Daschle's blueprint for health reform
- Kaiser Permanente gets perfect four-star rating on HMO score card